“…3 There is an expectation that physicians should try to reduce these costs by making a positive diagnosis of IBS, using symptom-based diagnostic criteria, whilst simultaneously minimizing invasive investigations. 4,5 Physicians may be reluctant to adopt this approach in clinical practice, as GI diseases manifest as a limited repertoire of symptoms, and those of IBS can mimic organic diseases such as inflammatory bowel disease, 6 microscopic colitis, 7 bile acid diarrhea, 8,9 or celiac disease. 10 The current "gold standard" for symptom-based diagnosis of IBS are the Rome III criteria, 1 but these have only been validated in one large study from Canada, 11 and performed modestly in distinguishing IBS from organic GI disease.…”